How the pharma industry is changing to produce a Covid vaccine on time

Vaccine experts explain how big pharma is adapting to the pandemic

Woman receives an injection of a Covid vaccine during a clinical trial.
(Image credit: Joe Raedle/Getty Images)

Beatrice Melinek, post-doctoral research fellow in biochemical engineering at University College London (UCL) and Stephen Morris, research fellow in vaccine process analytics at UCL, on how the industry is evolving to deliver a response to Covid.

To bring Covid-19 under control a vaccine needs to be available to every nation, rich and poor – and it needs to happen quickly. But pharmaceutical breakthroughs are usually the result a slow process involving competition, secrecy, risky investments and extensive trials.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up